Skip to content
VC FundPuts its own capital into companiesLAST VERIFIED Oct 2026 · 8 SOURCES

Nucleus Capital

Also known as Nucleus Capital Fund Management GmbH, Nucleus Capital Fund II, Nucleus

Berlin first-cheque deep-tech VC (up to €1.0m) for technical teams in programmable biology, food technology and neo industrials in Europe and the US; Fund II targets €40m.

Berlin pre-seed/seed deep-tech VC (programmable biology, food tech, neo industrials); not Nucleus Capital entities in other countries or Nucleus Ventures.

HEADQUARTERS
Berlin, Germany
FOUNDED
—
AUM
—
OUTSIDE CAPITAL
Yes
TEAM LISTED
7 people

Focus

STAGES
Pre-SeedSeed
ASSET MIX
Venture capitalImpact
GEOGRAPHY
EuropeNorth America

Overview

Nucleus Capital is a Berlin venture capital firm that writes first cheques of up to €1.0m, leading or co-leading pre-seed and seed rounds for technical teams in programmable biology, food technology and neo industrials (energy, manufacturing, materials and supply chains), with a concentrated portfolio across Europe and the US. It is led by General Partners Dr. Isabella Fandrych and Maximilian Schwarz. Its second fund, Nucleus Capital Fund II GmbH & Co. KG, had a first closing of €10.4m in March 2024 against a €40m target, and in July 2024 received a €6.5m commitment as the first fund backed by KfW Capital's Emerging Manager Facility. Portfolio companies include Planet A Foods, Apoha, Endolith, Planetary and Juicy Marbles.

Investment thesis

First-cheque, thesis-driven investing in technical founders 'rewiring the fabric of modern life through biology, food, and industrial systems': programmable biology (computation meets biology), food technology (agriculture, food production and distribution) and neo industrials (energy, manufacturing, materials, supply chains for a resource-constrained world), with a support model built for scientific ventures.

PORTFOLIO (39)

  • Food & Agriculture
  • ApohaNOTABLE
    Artificial Intelligence
  • Biotech & Life Sciences
  • Space
  • Climate & Energy
  • Food & Agriculture
  • Industrial & Manufacturing
  • Food & Agriculture
  • Food & Agriculture
  • Biotech & Life Sciences
  • Climate & Energy
  • Food & Agriculture
  • Biotech & Life Sciences
  • Fintech
  • Evasive Robotics
    Industrial & Manufacturing
  • Evolv
    Biotech & Life Sciences
  • Farmless
    Food & Agriculture
  • Infyos
    Climate & Energy
  • Izote Biosciences
    Biotech & Life Sciences
  • Juicy Marbles
    Food & Agriculture
  • Koppie
    Food & Agriculture
  • Magmatic
    Biotech & Life Sciences
  • Magnify
    Industrial & Manufacturing
  • Metabologic
    Biotech & Life Sciences
  • Officinae Bio
    Biotech & Life Sciences
  • Planetary
    Biotech & Life Sciences
  • Repath
    Climate & Energy
  • Rhizocore Technologies
    Climate & Energy
  • Root Global
    Food & Agriculture
  • Ruby Bio
    Biotech & Life Sciences
  • ScienceMachine
    Artificial Intelligence
  • Spark E-Fuels
    Climate & Energy
  • Telura
    Climate & Energy
  • Trilobio
    Biotech & Life Sciences
  • Triple Bio
    Food & Agriculture
  • Ucaneo
    Climate & Energy
  • Food & Agriculture
  • Industrial & Manufacturing
  • Artificial Intelligence

People

Links

Frequently asked questions

Nucleus Capital is a VC fund based in Berlin, Germany.

Yes. Nucleus Capital invests its own capital in private companies.

Nucleus Capital invests at Pre-Seed and Seed stages in Biotech & Life Sciences, Food & Agriculture, Climate & Energy, Industrial & Manufacturing and Deep Tech.

Nucleus Capital's stated ticket size is Up to €1M.

Key people at Nucleus Capital include Dr. Isabella Fandrych (General Partner (Neo Industrials, corporate relationships); Managing Director), Maximilian Schwarz (General Partner (Food Tech, Programmable Biology); Managing Director), Dr. Carolina Villa (Principal (Programmable Biology)) and Raffael Wohlgensinger (Venture Partner).

Nucleus Capital's investments include Planet A Foods, Apoha, Endolith, Yuri, Atmio, AtmoCooling, Batch Robotics and Bindbridge, among others.

Nucleus Capital states that it accepts submissions through its official contact page.

Yes. Nucleus Capital manages capital from outside investors.